Now on stands: Your drug may be spurious

The business of spurious drugs in India

GN Bureau | April 29, 2016


#Curtain Raiser   #Dinesh Thakur   #Health   #Medicines  


Indu Gilra, a retired teacher in her seventies living in Indirapuram, Ghaziabad in the national capital region (NCR), would often pop a tablet of Combiflam at the slightest hint of body ache. Since it’s an over-the-counter medicine, she could purchase it anywhere and it had always worked. One day, however, the pain refused to subside hours after taking the pill. Worried, she doubled her dose and yet the pain wouldn’t budge.

“I kept wondering if I had contracted some serious disease,” she says. She also wondered if there was something wrong with the medicine – she had bought it from a chemist’s shop which had opened recently in her middle-class neighbourhood. Maybe she should change the shop and not the medicine, she thought. Indu’s pain was gone after buying a strip of the same medicine from another pharmacist.
“I could make out that I had been popping spurious drugs all these days, but what could I do?”

Upset at being cheated she now decided to spread the word about her experience and at least expose the pharmacist before others. Her friend and neighbour Jaya Bhat, 74, was suffering from hypothyroidism – a condition in which a small gland located deep inside the neck region becomes sluggish and does not produce enough thyroxin hormone that plays a key role in working of the human body. For years, Jaya had been popping a 50 mg pill of Thyroxin in the morning to allow her body to make up for the missing hormone. However, of late, she had been feeling very uncomfortable, suffering palpitation, feeling extreme cold even in the peak of Delhi summer and her body bloating.

Fearing that her thyroid condition might have worsened, she got her blood tested. The doctor saw the report of the clinical test and told her that the gland had become even more sluggish and now she needed to double the dose to compensate for ever lower levels of thyroxin.
One day when the neighbours met during a routine walk they exchanged notes on health. Indu let out her rant against the new chemist. “I was lucky to have met Indu that day,” recalls Jaya, a homemaker, who too realised why she was continuing to suffer even after doubling her dose of medicine. She too changed her druggist and heaved a sigh of relief.

She has since returned to the 50-mg pill regime. “Only last week I got my blood tested for thyroxin and the result was normal,” she says.
The two women not only wasted money and suffered pain and anxiety but also consumed chemicals which could have major side effects on their health. Unfortunately, Indu and Jaya live in a region – NCR Delhi – which sees a Rs 300 crore substandard drugs trade each year. According to the industry body Associated Chambers of Commerce of India (ASSOCHAM), a third of the drugs sold in this region comprising the capital and the four townships around it – Noida, Ghaziabad, Faridabad and Gurgaon, with a total population of 4.6 crore – are substandard. The report is based on a survey it carried out in 2006-07.

Read full story about the business of spurious drugs in India in May 1-15, 2016 issue

Comments

 

Other News

“Indians, yet treated like outsiders”

Moving to Delhi-NCR for education can be an exciting experience for students from Northeast India. It gives us a chance to meet new people, experience a different culture and become more independent. But living away from home also comes with challenges that people who have not experienced them may not al

Import duty on major edible oils cut

The government has reduced the Basic Customs Duty (BCD) on major imported crude edible oils with a view to moderating domestic edible oil prices, providing relief to consumers and mitigating inflationary pressures arising from the sharp increase in international edible oil prices.  

From pyramid to platform: BRICS agenda for Global South

In his opening address at the 18th BRICS Summit in New Delhi on September 12, prime minister Narendra Modi did something India`s diplomacy has been building towards for three years: he moved the ‘Voice of the Global South’ from a slogan to a work plan. Addressing the leaders, he argued that t

How to realise the full transformative potential of PM-JAY

The Pradhan Mantri Jan Arogya Yojana (PM-JAY), a welfare scheme which covers approximately 45 crore beneficiaries across India, provides cashless health cover of Rs. 5 lakh per family per year. It is the largest health insurance scheme which helped crores of poor families by reducing out-of-pocket expend

The missing men in India`s family planning story

Every pregnancy requires two people. Yet India`s family planning programme continues to ask only one of them to bear almost all of its medical consequences. The newly released National Family Health Survey-6 (2023-24) confirms just how entrenched this asymmetry remains: 36.5% of currently married women a

`Development must be judged beyond GDP, with rights and justice at core`

Delivering the IXth Chief Justice M.C. Chagla Memorial Lecture on ‘Human Rights and Sustainable Development Goals’, in Mumbai Friday,  former Chief Justice of India Bhushan R. Gavai questioned whether conventional economic indicators such as gross domestic product (GDP), national income,

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter